Sign in

CIK 0001001316

  • Large accelerated filer

TG THERAPEUTICS, INC.

Sign in to watch
Ticker
TGTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363898269
Phone
+1 212-554-4484
Business address
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
Former names
MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
  1. 4 Grant or award CEO acquired 750,000 shares (grant or award)
  2. 4 Grant or award CFO acquired 87,500 shares (grant or award)
  3. 4 Open-market sale CFO sold 21,358 shares at an average $29.47 ($629,382)
  4. 4 Open-market sale Director sold 5,000 shares at $30.44 ($152,200)
  5. 4 Open-market sale Director sold 25,000 shares at $30.20 ($754,875)
  6. 4 Open-market sale Director sold 20,000 shares at $24.48 ($489,600)
  7. 4 Open-market sale Director sold 25,933 shares at an average $16.69 ($432,889)
  8. 4 Grant or award Director acquired 22,250 shares (grant or award)
  9. 4 Grant or award Director acquired 22,250 shares (grant or award)
  10. 4 Grant or award Director acquired 22,250 shares (grant or award)
  11. 4 Grant or award Director acquired 22,250 shares (grant or award)
  12. 4 Open-market sale Director sold 5,000 shares at $15.94 ($79,675)
  13. 4 Open-market sale Director sold 22,000 shares at $15.97 ($351,340)
  14. 5 Insider Annual Insider Trading Report
  15. 4 Open-market sale Director sold 17,500 shares at $19.03 ($333,025)
  16. 4 Grant or award CEO acquired 1,001,908 shares (grant or award)
  17. 4 Open-market sale CFO sold 47,867 shares at $16.91 ($809,431)
  18. 4 Grant or award Director acquired 20,000 shares (grant or award)
  19. 4 Grant or award Director acquired 20,000 shares (grant or award)
  20. 4 Grant or award Director acquired 20,000 shares (grant or award)

Page 2 of 18 · 353 filings